ATXS - Astria Therapeutics, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 9.73

Open

$ 10.03

Bid

$ 0.00 x 0

Ask

$ 9.74 x 100

Day's Range

$ 9.49 - $ 10.12

52 Week Range

$ 4.26 - $ 16.90

Volume

443,655

Average Volume

Market Cap

271.9M

Beta (5Y Monthly)

$ 1.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-04-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-07-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-22-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-11-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-10-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-14-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-15-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-12-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-13-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Astr...
05/10/2024 19:00:27

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $16 p...

Wedbush Reiterates Outperform on Astria Th...
05/10/2024 13:36:41

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $22 price target.

Astria Therapeutics Q1 2024 GAAP EPS $(0.3...
05/09/2024 21:36:24

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate.

HC Wainwright & Co. Maintains Buy on Astri...
04/23/2024 10:22:29

HC Wainwright & Co. analyst Joseph Pantginis maintains Astria Therapeutics (NASDAQ:ATXS) with a Buy and lowers the price...

Wedbush Maintains Outperform on Astria The...
03/26/2024 13:34:23

Wedbush analyst Laura Chico maintains Astria Therapeutics (NASDAQ:ATXS) with a Outperform and raises the price target from $...

HC Wainwright & Co. Maintains Buy on Astri...
03/25/2024 16:35:33

HC Wainwright & Co. analyst Joseph Pantginis maintains Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 pr...

Astria Therapeutics shares are trading hig...
03/25/2024 12:43:42

Astria Therapeutics Announces Initial Proo...
03/25/2024 11:40:03

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...

why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Lifecore Biomedical Shares Are Trading...
03/20/2024 18:03:46

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

HC Wainwright & Co. Reiterates Buy on Astr...
03/14/2024 11:13:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 p...

Wedbush Reiterates Outperform on Astria Th...
03/05/2024 13:34:27

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $17 price target.

HC Wainwright & Co. Reiterates Buy on Astr...
03/05/2024 12:04:35

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 p...

Astria Therapeutics Q4 EPS $(0.86) Down Fr...
03/04/2024 21:20:25

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.86) per share. This is a 19.44 percent decrease over losses ...

Wedbush Reiterates Outperform on Astria Th...
01/30/2024 16:02:17

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $17 price target.

Astria Therapeutics Announces Pricing Of $...
01/30/2024 14:25:53

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/25/2024 13:06:00

Astria Therapeutics 13G Filing Shows TCG C...
01/16/2024 21:24:23

- SEC Filing

56m-bet-on-this-real-estate-stock-check-out-these-3-stocks-insiders-are-buying

$5.6M Bet On This Real Estate Stock? Check...
12/26/2023 11:49:08

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Oppenheimer Maintains Outperform on Astria...
11/15/2023 18:12:00

Oppenheimer analyst Hartaj Singh maintains Astria Therapeutics (NASDAQ:ATXS) with a Outperform and lowers the price target f...

Astria Therapeutics Q3 EPS $(0.63) Vs $(0....
11/13/2023 13:03:36

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.63) per share. This is a 27.59 percent increase over losses ...